StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Piper Jaffray Reiterates Overweight Rating on Amgen (AMGN)
August 22, 2019 12:45 PM
Piper Jaffray analyst Christopher Raymond reiterated an Overweight rating and $210.00 price ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot Comments
Next Articles
Amgen (AMGN) to Acquire Otezla from Celgene (CELG) for $13.4B
August 26, 2019 6:32 AM